Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
US Department of Justice
Farmers Insurance
Julphar
Boehringer Ingelheim
Novartis
Accenture
Fish and Richardson
Express Scripts

Generated: October 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Abstract: This disclosure provides methods and compositions for inhibiting immune responses. The disclosure also provides methods and compositions for inhibiting graft rejection and promoting or prolonging graft survival.
Inventor(s): Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT)
Assignee: Alexion Pharmaceuticals, Inc. (New Haven, CT)
Application Number:14/080,457
Patent Claim Types:
see list of patent claims
Use;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biogen
ZINBRYTA
daclizumab
INJECTABLE;INJECTION7610290012016-05-27► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXsearch
Genzyme
LEMTRADA
alemtuzumab
INJECTABLE;INJECTION1039480032001-05-07► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXOrphansearch
Genzyme
CAMPATH
alemtuzumab
VIAL; INTRAVENOUS1039480022001-05-07► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXOrphansearch
Genzyme
CAMPATH
alemtuzumab
VIAL; INTRAVENOUS1039480012001-05-07► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXOrphansearch
Novartis
SIMULECT
basiliximab
VIAL; SINGLE-USE1037640021998-05-12► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXsearch
Novartis
SIMULECT
basiliximab
VIAL; SINGLE-USE1037640011998-05-12► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXsearch
Genentech
RITUXAN
rituximab
VIAL1037050011997-11-26► Subscribe Alexion Pharmaceuticals, Inc. (New Haven, CT) Rother; Russell P. (Oklahoma City, OK), Faas McKnight; Susan (Old Lyme, CT) ► SubscribeRXsearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

PCT Information
PCT FiledJuly 25, 2008PCT Application Number:PCT/US2008/009037
PCT Publication Date:January 29, 2009PCT Publication Number: WO2009/014745

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fuji
Novartis
Chinese Patent Office
Baxter
Covington
US Army
UBS
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot